Luping Wang

519 total citations
33 papers, 395 citations indexed

About

Luping Wang is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Luping Wang has authored 33 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Luping Wang's work include PARP inhibition in cancer therapy (4 papers), Colorectal Cancer Screening and Detection (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Luping Wang is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Colorectal Cancer Screening and Detection (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Luping Wang collaborates with scholars based in China, Hong Kong and Japan. Luping Wang's co-authors include Peiqing Liu, Panxia Wang, Jing Lü, Zhuo-ming Li, Zhenzhen Li, Yuehuai Hu, Juan Shen, Junjian Wang, Rui Lan and Jiantao Ye and has published in prestigious journals such as Chemical Engineering Journal, British Journal of Pharmacology and Journal of Experimental Biology.

In The Last Decade

Luping Wang

31 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luping Wang China 12 153 98 69 48 44 33 395
Vadim Mitrokhin Russia 11 145 0.9× 106 1.1× 21 0.3× 71 1.5× 39 0.9× 50 351
Jieyu Liu China 12 228 1.5× 33 0.3× 51 0.7× 37 0.8× 39 0.9× 51 465
Dong Zheng China 10 248 1.6× 107 1.1× 17 0.2× 47 1.0× 92 2.1× 12 413
Shamim Chowdhury United States 13 393 2.6× 194 2.0× 30 0.4× 46 1.0× 37 0.8× 24 593
Zhihao Zhang China 12 186 1.2× 23 0.2× 30 0.4× 28 0.6× 89 2.0× 39 383
Xiaoyan Min China 8 222 1.5× 87 0.9× 28 0.4× 35 0.7× 60 1.4× 16 398
Elizabeth C. Hinchy United Kingdom 8 366 2.4× 46 0.5× 23 0.3× 98 2.0× 91 2.1× 11 602
Jong Geol Lee South Korea 12 140 0.9× 17 0.2× 24 0.3× 38 0.8× 27 0.6× 26 367
Qinghua Liang China 11 178 1.2× 19 0.2× 40 0.6× 64 1.3× 39 0.9× 30 391
Irmgard Schuiki Canada 10 301 2.0× 81 0.8× 22 0.3× 84 1.8× 116 2.6× 12 660

Countries citing papers authored by Luping Wang

Since Specialization
Citations

This map shows the geographic impact of Luping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luping Wang more than expected).

Fields of papers citing papers by Luping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luping Wang. The network helps show where Luping Wang may publish in the future.

Co-authorship network of co-authors of Luping Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Luping Wang. A scholar is included among the top collaborators of Luping Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luping Wang. Luping Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wei, Mingyan Li, Zhimin Gao, et al.. (2025). RAB7 protects against ischemic heart failure via promoting non-canonical TUFM mitophagy pathway. Theranostics. 15(14). 6753–6767.
2.
Wang, Panxia, Luping Wang, Cui Liu, et al.. (2024). YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice. Pharmacological Research. 211. 107573–107573. 2 indexed citations
3.
Fan, Caiyun, Luping Wang, Lei Gao, et al.. (2022). Ascorbic acid regulates mouse spermatogonial stem cell proliferation in a Wnt/β-catenin/ROS signaling dependent manner. Theriogenology. 184. 61–72. 6 indexed citations
4.
Yu, Wancong, Wenwen Wu, Nan Zhang, et al.. (2022). Research Advances on Molecular Mechanism of Salt Tolerance in Suaeda. Biology. 11(9). 1273–1273. 14 indexed citations
5.
Liu, Xingdan, Luping Wang, Zhao Jin, et al.. (2022). Simvastatin-loaded sulfonated PEEK enhances angiogenesis and osteogenesis via miR-29cb2-mediated HIF-3α downregulation. Chemical Engineering Journal. 448. 137738–137738. 8 indexed citations
6.
Wang, Luping, Panxia Wang, Suowen Xu, et al.. (2021). The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy. International Journal of Biological Sciences. 18(2). 783–799. 8 indexed citations
8.
Wang, Luping, et al.. (2019). Agenesis of the dorsal pancreas presenting with diabetic ketoacidosis – a case report and literature review. BMC Endocrine Disorders. 19(1). 120–120. 7 indexed citations
9.
Hong, Huiling, Wenwei Luo, Chunmei Dai, et al.. (2018). mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway. Acta Pharmacologica Sinica. 39(12). 1837–1846. 32 indexed citations
10.
Li, Qian, Zhuo-ming Li, Shuya Sun, et al.. (2018). PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy. Acta Pharmacologica Sinica. 40(5). 589–598. 21 indexed citations
11.
Xue, Yangjing, Xiaoning Wang, Saroj Thapa, et al.. (2017). Very early recurrence predicts long-term outcome in patients after atrial fibrillation catheter ablation: a prospective study. BMC Cardiovascular Disorders. 17(1). 109–109. 14 indexed citations
12.
Zheng, Cheng, et al.. (2016). Where is the exact origin of narrow premature ventricular contractions manifesting qR in inferior wall leads?. BMC Cardiovascular Disorders. 16(1). 64–64. 4 indexed citations
13.
Liu, Min, Zhe Li, Zhuo-ming Li, et al.. (2014). AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy. Molecular and Cellular Endocrinology. 392(1-2). 14–22. 26 indexed citations
14.
Cheng, Zheng, Jin Li, Ye Wan, et al.. (2014). A new method of building permanent A-V block model: ablating his-bundle potential through femoral artery with pre-implanted biventricular pacemaker. BMC Cardiovascular Disorders. 14(1). 164–164. 1 indexed citations
15.
Xu, Sheng, Luping Wang, Lin Li, et al.. (2013). Clinicopathological observations of colorectal serrated lesions associated with invasive carcinoma and high-grade intraepithelial neoplasm. Experimental and Therapeutic Medicine. 6(5). 1113–1120. 3 indexed citations
16.
Wang, Luping, Xiaojun Dai, Liying Zhang, et al.. (2012). The expression and mutation of β-catenin in colorectal traditional serrated adenomas. Indian Journal of Pathology and Microbiology. 55(3). 288–288. 3 indexed citations
17.
Wang, Luping. (2010). Focus on the ADR Charicteristics of Traditional Chinese Herbal Medicine and its Prevent Measures from the Liver Damage by Poligoni Multiflori Radix. 1 indexed citations
18.
Zhang, Linsheng, et al.. (2009). Cloning and sequence analysis of a new dehydrin gene (WZY2) from wheat.. Journal of Northwest A&F University. 37(2). 93–99. 6 indexed citations
19.
Wang, Luping, et al.. (2002). A Case-Control Study of Risk Factors for Development of Type 2 Diabetes: Emphasis on Physical Activity.. Journal of Epidemiology. 12(6). 424–430. 10 indexed citations
20.
Yu, Jiyao, et al.. (1992). Studies of nucleolar organizer regions and mucin histochemistry in ulcerative colitis. Chinese Journal of Cancer Research. 4(2). 43–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026